Oral paracetamol versus oral ibuprofen for closure of haemodynamically significant patent ductus arteriosus in preterm neonates (<32 weeks): a blinded, randomised, active-controlled, non-inferiority trial

INTRODUCTION: Haemodynamically significant patent ductus arteriosus (hsPDA) is a common cause of mortality and morbidity in preterm infants. Existing medical therapies with ibuprofen or indomethacin have multiple adverse effects. Hence, an alternative drug like paracetamol given through oral route w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Ashutosh, Sundaram, Venkataseshan, Yadav, Rahul, Oleti, Tejo Pratap, Murki, Srinivas, Krishna, Arun, Sundaram, Mangalabharathi, Saini, Shiv Sajan, Dutta, Sourabh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862198/
https://www.ncbi.nlm.nih.gov/pubmed/29637155
http://dx.doi.org/10.1136/bmjpo-2017-000143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862198/
https://www.ncbi.nlm.nih.gov/pubmed/29637155
http://dx.doi.org/10.1136/bmjpo-2017-000143

Ejemplares similares